Category : Search result: Darolutamide

Navin Fluorine Stock Up 80% on CDMO Growth, Export Boom

Navin Fluorine International rallies 80% in 2025 as CDMO revenues double, Darolutamide orders ramp up, and new capacity boosts FY26 outlook. Strong margin expansion fuels investor optimism.